BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 4748254)

  • 1. Combination chemotherapy in advanced Hodgkin's disease. Induction and maintenance of remission.
    Frei E; Luce JK; Gamble JF; Coltman CA; Constanzi JJ; Talley RW; Monto RW; Wilson HE; Hewlett JS; Delaney FC; Gehan EA
    Ann Intern Med; 1973 Sep; 79(3):376-82. PubMed ID: 4748254
    [No Abstract]   [Full Text] [Related]  

  • 2. Combination chemotherapy of Hodgkin's disease.
    Nison DW; Aisenberg AC
    Cancer; 1974 Jun; 33(6):1499-504. PubMed ID: 4834147
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination chemotherapy of advanced Hodgkin's disease. A review.
    Goldsmith MA; Carter SK
    Cancer; 1974 Jan; 33(1):1-8. PubMed ID: 4129559
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease].
    Aghai E; Kende G; Many A; Ramot B
    Harefuah; 1974 Apr; 86(7):348-51. PubMed ID: 4846045
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy as a primary treatment of Hodgkin's disease (204 new cases, 1 to 8 years of follow-up).
    Jacquillat C; Weil M; Auclerc G; Desprez-Curely JP; Chastang C; Garçon C; Chantalou JP; Gemon-Auclerc MF; Delobel J; Dana M; Tanzer J; Teillet F; Izrael V; Chelloul N; Weisgerber C; De Heaulme M; Boiron M; Bernard J
    Eur J Cancer (1965); 1975 Oct; 11(10):679-88. PubMed ID: 1204663
    [No Abstract]   [Full Text] [Related]  

  • 6. Prednisone in MOPP chemotherapy for Hodgkin's disease.
    Jacobs C; Portlock CS; Rosenberg SA
    Br Med J; 1976 Dec; 2(6050):1469-71. PubMed ID: 1000259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) vs. nitrogen mustard in advanced Hodgkin's disease.
    Huguley CM; Durant JR; Moores RR; Chan YK; Dorfman RF; Johnson L
    Cancer; 1975 Oct; 36(4):1227-40. PubMed ID: 1175125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy in Hodgkin's disease at advanced stages.
    Focan C; Bricteux N; Lemaire M; Hugues J
    Acta Clin Belg; 1975; 30(4):298-309. PubMed ID: 1211050
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy of Hodgkin's disease. Maintenance therapy vs no maintenance after remission induction with combination chemotherapy.
    Luce JK; Frei E; Gehan EA; Coltman CA; Talley R; Monto RW
    Arch Intern Med; 1973 Mar; 131(3):391-5. PubMed ID: 4688037
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chemotherapy of advanced stages (IIIB and IV) of Hodgkin's disease].
    Michaux JL; Ferrant A; Hulhoven R; Rodhain J; Cornu G; Naets E; Dutriéux-Fauchet MC; Stenuit L; Sokal G
    Acta Clin Belg; 1975; 30(4):310-6. PubMed ID: 1211051
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter: Chemotherapy of Hodgkin's disease.
    Winokur SH
    N Engl J Med; 1974 Dec; 291(24):1309. PubMed ID: 4431438
    [No Abstract]   [Full Text] [Related]  

  • 12. MOPP chemotherapy for advanced Hodgkin's disease. Prognostic factors in 81 patients.
    Moore MR; Jones SE; Bull JM; William LA; Rosenberg SA
    Cancer; 1973 Jul; 32(1):52-60. PubMed ID: 4716784
    [No Abstract]   [Full Text] [Related]  

  • 13. Combination chemotherapy and survival in advanced Hodgkin's disease.
    Canellos GP; Young RC; Berard CW; DeVita VT
    Arch Intern Med; 1973 Mar; 131(3):388-90. PubMed ID: 4569375
    [No Abstract]   [Full Text] [Related]  

  • 14. Value of prednisone in combination chemotherapy of stage IV Hodgkin's disease. Report from the British National Lymphoma Investigation.
    Br Med J; 1975 Aug; 3(5980):413-4. PubMed ID: 1098721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined chemotherapy in Hodgkin's disease].
    Somers R; Haanen C; Hart AA; Kroese WF; Sizoo W; Wagener DJ
    Ned Tijdschr Geneeskd; 1976 Jun; 120(24):1038-43. PubMed ID: 1272447
    [No Abstract]   [Full Text] [Related]  

  • 16. [Polychemotherapy of Hodgkin's disease. Long-term results in 226 cases].
    Jacquillat C; Auclerc G; Gemon-Auclerc MF; Weil M; Chastang C; Boiron M; Bernard J
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):473-83. PubMed ID: 917836
    [No Abstract]   [Full Text] [Related]  

  • 17. [Combination chemotherapy (MOPP) in 60 patients with Hodgkin's disease (five years results) (author's transl)].
    Lauria F; Baccarani M; Barbieri E; Fiacchini M; Gobbi M; Tura S; Baccarani M
    Haematologica; 1975 Mar; 60(1):73-84. PubMed ID: 806500
    [No Abstract]   [Full Text] [Related]  

  • 18. [Post-MOPP chemotherapy of Hodgkin's disease (author's transl)].
    Osieka R; Bruntsch U; Gallmeier WM; Seeber S; Schmidt CG
    Dtsch Med Wochenschr; 1976 Aug; 101(32):1177-82. PubMed ID: 59661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Letter: Therapy for Hodgkin's disease.
    Young RC; DeVitra VT; Frei E; DeWys D
    Ann Intern Med; 1974 Feb; 80(2):274-6. PubMed ID: 4811802
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter: Chemotherapy of Hodgkin's disease.
    Olweny CL; Mbidde EK; Nkwocha J; Magrath I; Ziegler JL
    Lancet; 1974 Dec; 2(7893):1397. PubMed ID: 4143364
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.